Search research articles
Contact Us
Filters
Showing results (281-290 of 323) with videos related to
Page
of 33
Sort By:
Nature Genetics
|
October 9, 2012
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J Molenaar, Raquel Domingo-Fernández, Marli E Ebus, et al.
Nature Communications
|
March 7, 2023
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
Bieke Decaesteker, Amber Louwagie, Siebe Loontiens, et al.
Nature Communications
|
March 10, 2026
Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage
Irina Poverennaya, Aliia Murtazina, Lei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
André Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
EMBO Molecular Medicine
|
July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma
Hamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Molecular Cancer
|
June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Mareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Nature Communications
|
November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35
Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
The Lancet. Oncology
|
June 12, 2009
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joëlle Vermeulen, Katleen De Preter, Arlene Naranjo, et al.
Cancer Research
|
September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Jessica Koach, Jessica K Holien, Hassina Massudi, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 323) with videos related to
Sort By:
Page
of 33
Nature Genetics
|
October 9, 2012
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J Molenaar, Raquel Domingo-Fernández, Marli E Ebus, et al.
Nature Communications
|
March 7, 2023
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
Bieke Decaesteker, Amber Louwagie, Siebe Loontiens, et al.
Nature Communications
|
March 10, 2026
Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage
Irina Poverennaya, Aliia Murtazina, Lei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
André Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
EMBO Molecular Medicine
|
July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma
Hamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.
Molecular Cancer
|
June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Mareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Nature Communications
|
November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35
Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
The Lancet. Oncology
|
June 12, 2009
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joëlle Vermeulen, Katleen De Preter, Arlene Naranjo, et al.
Cancer Research
|
September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Jessica Koach, Jessica K Holien, Hassina Massudi, et al.
Page
of 33